These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 35704715)

  • 1. Antinuclear Antibody Among Post COVID-19 Cases: a Preliminary Report.
    Sookaromdee P; Tin SS; Wiwanitkit V
    Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704715
    [No Abstract]   [Full Text] [Related]  

  • 2. Post COVID-19 joint pain: Preliminary report of the relationship with antinuclear antibodies and inflammation.
    Tamariz L; Bast E; Abad M; Klimas N; Caralis P; Palacio A
    J Med Virol; 2022 Aug; 94(8):3479-3481. PubMed ID: 35355291
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of antinuclear antibodies in COVID-19 patients.
    Beenet L
    J Immunol Methods; 2022 Mar; 502():113215. PubMed ID: 34998816
    [No Abstract]   [Full Text] [Related]  

  • 4. Antinuclear antibodies in COVID 19.
    Muratori P; Lenzi M; Muratori L; Granito A
    Clin Transl Sci; 2021 Sep; 14(5):1627-1628. PubMed ID: 33932091
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic.
    Sjöwall J; Azharuddin M; Frodlund M; Zhang Y; Sandner L; Dahle C; Hinkula J; Sjöwall C
    Front Immunol; 2021; 12():724047. PubMed ID: 34512651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia.
    Gazzaruso C; Carlo Stella N; Mariani G; Nai C; Coppola A; Naldani D; Gallotti P
    Clin Rheumatol; 2020 Jul; 39(7):2095-2097. PubMed ID: 32462425
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antinuclear antibodies in rheumatology].
    Zuber M
    Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical importance of antinuclear antibodies].
    Dabelić N; Cikes N
    Lijec Vjesn; 1997; 119(8-9):236-42. PubMed ID: 9481891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomorphological characterisation of antinuclear antibodies in chronic liver disease.
    Cassani F; Bianchi FB; Lenzi M; Volta U; Pisi E
    J Clin Pathol; 1985 Jul; 38(7):801-5. PubMed ID: 3894432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ANTI-MUSCLE AND ANTINUCLEAR ANTIBODIES DURING MYASTHENIA. DETECTION BY THE IMMUNOFLUORESCENCE TECHNIC. PRELIMINARY NOTE].
    THIVOLET J; KRATCHKO A
    Rev Fr Etud Clin Biol; 1964 Feb; 9():212-5. PubMed ID: 14139829
    [No Abstract]   [Full Text] [Related]  

  • 11. Intracellular and circulating neuronal antinuclear antibodies in human epilepsy.
    Iffland PH; Carvalho-Tavares J; Trigunaite A; Man S; Rasmussen P; Alexopoulos A; Ghosh C; Jørgensen TN; Janigro D
    Neurobiol Dis; 2013 Nov; 59():206-19. PubMed ID: 23880401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroconversion to antinuclear antibody negativity and its association with disease flare in patients with systemic lupus erythematosus.
    Kwon OC; Kim YG; Park JH; Park MC
    Lupus; 2020 Jun; 29(7):697-704. PubMed ID: 32279583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin isotype distribution of antinuclear antibodies in dogs with leishmaniasis.
    Lucena R; Ginel PJ
    Res Vet Sci; 1998; 65(3):205-7. PubMed ID: 9915144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive antinuclear antibody in peripheral T cell lymphoma: a case report.
    Hsu CM; Kuo SY; Chu SJ; Sheu LF; Chang DM
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Nov; 54(5):359-62. PubMed ID: 7834560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The optimization of techniques complex of serologic diagnostics of connective tissue systemic diseases].
    Lazareva NM; Lapin SV; Mazing AV; Bulgakova TV; Ilivanova EP; Maslianskiĭ AL; Totolian AA
    Klin Lab Diagn; 2011 Dec; (12):12-7. PubMed ID: 22416425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus erythematosus cell preparation, antinuclear factor and antideoxyribonucleic acid antibody incongruity in systemic lupus erythematosus.
    Chee YC
    Ann Acad Med Singap; 1983 Jan; 12(1):109-14. PubMed ID: 6190427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The principle antinuclear and anti-cytoplasmic antibodies in polymyositis and dermatomyositis. Study of 42 cases].
    Meyer O; Cremer-Legmann F; Haim T; Ryckewaert A
    Presse Med; 1987 Feb; 16(4):155-8. PubMed ID: 2950445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of antinuclear antibodies in women with recurrent pregnancy losses: a prospective controlled study.
    Harger JH; Rabin BS; Marchese SG
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):419-24. PubMed ID: 2783770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinuclear antibody determinations in Ro(SSA)-positive, antinuclear antibody--negative lupus and Sjögren's syndrome patients.
    Doré N; Synkowski D; Provost TT
    J Am Acad Dermatol; 1983 May; 8(5):611-5. PubMed ID: 6408145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID-19.
    Blagova O; Varionchik N; Zaidenov V; Savina P; Sarkisova N
    Eur J Immunol; 2021 Apr; 51(4):893-902. PubMed ID: 33368288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.